Evolus EOLS Business Segments — In-process research and development
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolus in its filing.
Tagged under the XBRL concept eols:ResearchAndDevelopmentInProcess1.
The official record: Evolus’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolus's business segments — in-process research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolus's business segments — in-process research and development?
- Evolus (EOLS) reported business segments — in-process research and development of $0 in Q4 2025.
- What is the long-term trend for Evolus's business segments — in-process research and development?
- Over 3 years (2022 to 2025), Evolus's business segments — in-process research and development has grown at a -100.0% compound annual growth rate (CAGR), from $2M to $0.
- What does business segments — in-process research and development mean?
- This represents the value assigned to research and development projects that are currently in progress and have not yet reached technological feasibility. It reflects the investment in future product pipelines or intellectual property that may generate future economic benefits. Tracking this helps investors evaluate the company's commitment to long-term innovation and future growth potential.